+972548034532 info@resultmed.com


CTC Test for Personalized Cancer Treatment



CTC liquid biopsy test is a diagnostic tool providing doctors and patients with a dual diagnosis of a malignant disease. During the test circulating tumor cells CTCs in the blood are calculated. Test also provides a drug examination for targeted treatment.


The CTC onco-test provides a report with qualitative and quantitative information about the targeted therapy.


Testing of circulating tumor cells helps to select the most effective personalized treatment adapted to the biological characteristics of the tumor.


With the help of a liquid biopsy you can find out which drugs are most effective for such oncological diseases as:



New diseases and conditions are being added to this list all the time as a result of new studies and confirmed clinical results.




CTC Liquid Biopsy test checks 70 mutations and sensitivity of the tumor to more than 110 drugs


The test itself consists of a combination of two unique methods for targeted treatment:


  • Checking the treating effect of more than 110 oncological drugs on the cancer cells elimination, including biological medications and immunotherapy drugs, such as Keytruda.
  • Mapping over 70 gene expressions and mutations, including RAS, BRAF, ALK-EML4 and rare ones, allows to create a molecular tumor profile.


Advantages of CTC Liquid Biopsy


  • Liquid Biopsy test is non-invasive and is based on blood sample. This method uses advanced technologies to detect cancer cells that have separated from the primary tumor and have entered the bloodstream to create metastases.
  • With the help of a Liquid Biopsy a thorough examination of the malignant tumors sensitivity for different treatments is carried out instead of trial and error method on the patient’s body.
  • During CTC onco-test the efficiency of a wide range of various drugs (immunotherapy, chemotherapy and targeted biological therapy) is checked.
  • It allows to save valuable time and avoid deterioration of the overall health due to toxic and ineffective treatment.


Why is it important to analyze cancer cells circulating in the blood?


A cancerous tumor consists of a cells set with various histological characteristics. Each mutation has different effect on the disease severity and the treatment result.


Circulating cancer cells CTCs in the blood have the most aggressive biological nature and are the latest version of the tumor.


Since cancer cells in the bloodstream can also become metastases, it is very important to detect them in time and select the most accurate and effective treatment to stop their spread.


CTC Liquid Biopsy test detects circulating tumor cells at an early stage of cancer, even if the cancer is not detected by other visual diagnostic methods like CT or MRI.


CTC test provides important information about the efficiency for the current medication treatment. Test allows early detection of metastatic disease recurrence or progression.



What information does CTC Liquid Biopsy test report contain?


CTC oncotest checks the actual effect of cancer drugs on living tumor cells.

The test report graphically shows the benefits of each drug and therapy.


Example of a CTC Liquid Biopsy report with the drug efficiency

The higher is the destruction of tumor cells the more the drug efficiency:

  • High efficiency – killing cancer cells level of over 80%
  • Medium efficiency – killing cancer cells level of 35-80%
  • Low efficiency – killing cancer cells level of 0-35%


** Example of a CTC Liquid Biopsy report: each of the columns represents the efficiency of a various cancer treatments. It can be seen that оn average 75% – 80% of drugs are ineffective.


How is a blood sample taken for CTC Liquid Biopsy in Israel?


  • If necessary, a registered nurse will come to patient’s place of living to take a blood sample.
  • According to the procedure, a Liquid Biopsy resembles a normal blood test. This is an advantage over standard biopsy techniques that cause many side effects.
  • The blood sample is then sent to the laboratory for a CTC test, where tumor cells are separated from healthy ones and sorted using advanced medical technology.
  • Tumor cells serve as “representatives” of the patient in the laboratory, where the testing of treatment options will be carried out.
  • The cancer cell test examines the efficiency of more than 110 drugs in 3 different test methods.
  • The higher killing rate of cancer cells the more tumor sensitivity and drug efficiency.
  • The Liquid Biopsy oncotest report will be obtained within two weeks after receiving the specimen sample in the laboratory.


Which drugs are tested during CTC Liquid Biopsy test?


During the laboratory study the sensitivity of circulating tumor cells in the blood to more than 110 drugs and oncological procedures is verified. Tested drugs include both FDA-approved innovative and promising therapies, which are still in clinical trials but may already be included in a patient therapy program.


CTC Liquid Biopsy is still the only test for chemotherapeutic drugs because it is an important component of the cancer treatment protocol.


What is the compatibility degree between test results and effect of treatment?


More than 15,000 patients with cancer took part during research in leading medical centers of Europe and USA. А match was found in about 80% of cases. The results of the test allowed:


  • To choose effective medicines.
  • To prevent the usage of drugs for which the tumor is resistant.
  • To eliminate the need for invasive biopsy.


Where is CTC test conducted?


The test is conducted in the leading European cancer laboratories MGCC, which have been working on the medical services market for over 15 years. It is managed by the best researchers in the molecular testing field for the selection of targeted cancer treatment.


The laboratory is ISO certified and it is the world leader in the field of CTC testing and Liquid Biopsy for drug treatment.


Personal and Scientific Information Support


After receiving the results you can contact us for clarification for maximum benefit with the report.


Upon request, the laboratory staff can answer any question about this report.


In our view, successful cancer treatment requires the full interaction of the three components:


  • oncologist involvement
  • advanced technology
  • patient’s motivation.



Should you want to be consulted about CTCLiquid Biopsy oncotest and get a list of personalized cancer treatments in your case, please contact us at +972 54-803-4532, email: info@resultmed.com or fill out the application form.


We will contact you as soon as possible.


ResultMed Team




ResultMed provides medical treatment organization and coordination services for foreign patients only.


       !מבקרים באתר היקרים, אנא שימו לב

.אנחנו חברה תיירות מרפא. אנו נותנים שרות פרטי לתיירים בלבד


For foreign patients:


Viber, WhatsApp, Telegram + 972 54 803 45 32



Are you a foreign patient? Please send your request